Showing codes 69097-444-02 Atazanavir — 69097-534-97 Phenylephrine Hydrochloride

69097-444-02 - Atazanavir
Firm: Cipla USA Inc.
Package Description: 30 CAPSULE, GELATIN COATED in 1 BOTTLE (69097-444-02)
Usage type: ORAL
HTML  TXT

69097-444-03 - Atazanavir
Firm: Cipla USA Inc.
Package Description: 60 CAPSULE, GELATIN COATED in 1 BOTTLE (69097-444-03)
Usage type: ORAL
HTML  TXT

69097-445-02 - Atazanavir
Firm: Cipla USA Inc.
Package Description: 30 CAPSULE, GELATIN COATED in 1 BOTTLE (69097-445-02)
Usage type: ORAL
HTML  TXT

69097-445-03 - Atazanavir
Firm: Cipla USA Inc.
Package Description: 60 CAPSULE, GELATIN COATED in 1 BOTTLE (69097-445-03)
Usage type: ORAL
HTML  TXT

69097-446-02 - Atazanavir
Firm: Cipla USA Inc.
Package Description: 30 CAPSULE, GELATIN COATED in 1 BOTTLE (69097-446-02)
Usage type: ORAL
HTML  TXT

69097-446-03 - Atazanavir
Firm: Cipla USA Inc.
Package Description: 60 CAPSULE, GELATIN COATED in 1 BOTTLE (69097-446-03)
Usage type: ORAL
HTML  TXT

69097-458-02 - Fenofibrate
Firm: Cipla USA Inc.
Package Description: 30 TABLET in 1 BOTTLE (69097-458-02)
Usage type: ORAL
HTML  TXT

69097-458-05 - Fenofibrate
Firm: Cipla USA Inc.
Package Description: 90 TABLET in 1 BOTTLE (69097-458-05)
Usage type: ORAL
HTML  TXT

69097-459-02 - Fenofibrate
Firm: Cipla USA Inc.
Package Description: 30 TABLET in 1 BOTTLE (69097-459-02)
Usage type: ORAL
HTML  TXT

69097-459-05 - Fenofibrate
Firm: Cipla USA Inc.
Package Description: 90 TABLET in 1 BOTTLE (69097-459-05)
Usage type: ORAL
HTML  TXT

69097-503-27 - Dihydroergotamine Mesylate Nasal
Firm: Cipla USA Inc.
Package Description: 8 VIAL in 1 KIT (69097-503-27) / 1 mL in 1 VIAL
Usage type: NASAL
HTML  TXT

69097-503-31 - Dihydroergotamine Mesylate Nasal
Firm: Cipla USA Inc.
Package Description: 1 VIAL in 1 KIT (69097-503-31) / 1 mL in 1 VIAL
Usage type: NASAL
HTML  TXT

69097-507-31 - Esomeprazole Magnesium
Firm: Cipla USA Inc.
Package Description: 30 FOR SUSPENSION in 1 CARTON (69097-507-31)
Usage type: ORAL
HTML  TXT

69097-508-31 - Esomeprazole Magnesium
Firm: Cipla USA Inc.
Package Description: 30 FOR SUSPENSION in 1 CARTON (69097-508-31)
Usage type: ORAL
HTML  TXT

69097-514-03 - Abacavir
Firm: Cipla USA Inc.
Package Description: 60 TABLET, FILM COATED in 1 BOTTLE (69097-514-03)
Usage type: ORAL
HTML  TXT

69097-516-07 - Cyclophosphamide
Firm: Cipla USA Inc.
Package Description: 100 CAPSULE in 1 BOTTLE (69097-516-07)
Usage type: ORAL
HTML  TXT

69097-517-07 - Cyclophosphamide
Firm: Cipla USA Inc.
Package Description: 100 CAPSULE in 1 BOTTLE (69097-517-07)
Usage type: ORAL
HTML  TXT

69097-521-31 - Isoproterenol
Firm: Cipla USA Inc.
Package Description: 25 AMPULE in 1 CARTON (69097-521-31) / 1 mL in 1 AMPULE
Usage type: INTRACARDIAC; INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
HTML  TXT

69097-522-35 - Isoproterenol
Firm: Cipla USA Inc.
Package Description: 10 AMPULE in 1 CARTON (69097-522-35) / 5 mL in 1 AMPULE
Usage type: INTRACARDIAC; INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
HTML  TXT

69097-524-44 - Diclofenac Sodium
Firm: Cipla USA Inc.
Package Description: 1 TUBE in 1 CARTON (69097-524-44) > 100 g in 1 TUBE
Usage type: TOPICAL
HTML  TXT

69097-526-03 - Tadalafil
Firm: Cipla USA Inc.
Package Description: 60 TABLET, FILM COATED in 1 BOTTLE (69097-526-03)
Usage type: ORAL
HTML  TXT

69097-526-16 - Tadalafil
Firm: Cipla USA Inc.
Package Description: 4 TABLET, FILM COATED in 1 CARTON (69097-526-16)
Usage type: ORAL
HTML  TXT

69097-527-34 - Esomeprazole Magnesium
Firm: Cipla USA Inc.
Package Description: 30 GRANULE, FOR SUSPENSION, EXTENDED RELEASE in 1 CARTON (69097-527-34)
Usage type: ORAL
HTML  TXT

69097-528-34 - Esomeprazole Magnesium
Firm: Cipla USA Inc.
Package Description: 30 FOR SUSPENSION in 1 CARTON (69097-528-34)
Usage type: ORAL
HTML  TXT

69097-529-34 - Esomeprazole Magnesium
Firm: Cipla USA Inc.
Package Description: 30 FOR SUSPENSION in 1 CARTON (69097-529-34)
Usage type: ORAL
HTML  TXT

69097-530-49 - Phytonadione
Firm: Cipla USA Inc.
Package Description: 5 TRAY in 1 CARTON (69097-530-49) > 5 AMPULE in 1 TRAY (69097-530-31) > 1 mL in 1 AMPULE
Usage type: INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
HTML  TXT

69097-531-53 - Pantoprazole Sodium Delayed-release
Firm: Cipla USA Inc.
Package Description: 30 PACKET in 1 CARTON (69097-531-53) / 1 SUSPENSION in 1 PACKET (69097-531-31)
Usage type: ORAL
HTML  TXT

69097-532-32 - Sodium Nitroprusside
Firm: Cipla USA Inc.
Package Description: 1 VIAL, SINGLE-DOSE in 1 CARTON (69097-532-32) > 2 mL in 1 VIAL, SINGLE-DOSE
Usage type: INTRAVENOUS
HTML  TXT

69097-533-02 - Tenofovir Disoproxil Fumarate
Firm: Cipla USA Inc.
Package Description: 30 TABLET in 1 BOTTLE (69097-533-02)
Usage type: ORAL
HTML  TXT

69097-533-15 - Tenofovir Disoproxil Fumarate
Firm: Cipla USA Inc.
Package Description: 1000 TABLET in 1 BOTTLE (69097-533-15)
Usage type: ORAL
HTML  TXT

69097-534-97 - Phenylephrine Hydrochloride
Firm: Cipla USA Inc.
Package Description: 25 VIAL, SINGLE-DOSE in 1 CARTON (69097-534-97) > 1 mL in 1 VIAL, SINGLE-DOSE (69097-534-31)
Usage type: INTRAVENOUS
HTML  TXT